The Daily Screen: The Best Health Care Funds
In a gory year for stocks, health care funds have been stars. That's where today's Daily Screen turns its attention.
These funds typically have the leeway to invest in drug makers of all sizes, HMOs, hospitals, medical device makers, or even software shops that help docs cut down on their business's paper chase. But over the past couple of years, the top health care funds have been those that focus on biotech companies, the small high-tech labs that develop new medications. Over the past year, the American Stock Exchange Biotechnology Index is up a startling 148%, according to Baseline. But it might be a pretty fatal mistake to plan on biotechs holding anything close to that pace. Yes, the mercurial sector is known for these types of performance bursts, but it's also known for long droughts. Consider that the same index posted a cumulative 3.3% loss from January 1993 to January 1996. So far in October, the index is off more than 16%. As usual, we've sifted the category for the funds that beat their average peer over the past one- and three-year periods, according to Morningstar. We came up with five and have ranked them by one-year return below. In addition to these, you might take a look at less biotech-heavy types. One candidate is (VGHCX)Vanguard Health Care, which has no load but a steep $10,000 minimum for nonretirement accounts; another is (FSPHX)Fidelity Select Health Care, which benefits from Fido's deep analytical bench but carries a maximum 3% front-end load or sales charge. We've also poked under the hood of the category's leading funds, listing their cumulative top holdings in a second chart. As you might imagine, the list skews toward biotech and drug shops. Consider top-three holdings Immunex(IMNX), MedImmune(MEDI) and biotech bellwether Amgen(AMGN).| Leading Healthcare Sector Funds These funds have trounced their peers and the broader market | ||
| Fund | 1-Year Return | 3-Year Annualized |
| (MFHAX)Munder Framlington Healthcare | 176.2% | 34.3% |
| (FBDIX)Franklin Biotechnology Discovery* | 138.2 | 41.0 |
| (DGHCX)Dresdner RCM Global Health Care | 113.1 | 35.6 |
| (ETHSX)Eaton Vance Worldwide Health Sciences | 96.1 | 31.9 |
| (FBIOX)Fidelity Select Biotechnology | 71.5 | 40.8 |
| Avg. Health Care Fund | 70.4 | 20.9 |
| (VFINX)Vanguard 500 Index | 2.6 | 12.7 |
| Source: Morningstar. Performance figures through Oct. 12. *Closed to new investors. | ||
| Under the Hood The stocks with the biggest weighting in the combined portfolios of the above five funds | ||
| Stock | Weighting in Top-Five Funds | Number of Top- Five Funds Owning the Stock |
| Immunex(IMNX) | 2.7% | 3 |
| MedImmune(MEDI) | 2.4 | 4 |
| Amgen(AMGN) | 2.2 | 3 |
| Genentech(DNA) | 1.9 | 4 |
| Chiron(CHIR) | 1.9 | 3 |
| IDEC Pharmaceuticals(IDPH) | 1.8 | 3 |
| Pfizer(PFE) | 1.6 | 3 |
| COR Therapeutics(CORR) | 1.6 | 3 |
| Inhale Therapeutics(INHL) | 1.6 | 4 |
| Millennium Pharmaceuticals(MLNM) | 1.6 | 3 |
| Source: Morningstar. Holdings as of most recent portfolio report. | ||
TheStreet Premium Services For Personal Service: 877-471-2967
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn MoreETF Profits:
Get money-making ideas from the hottest investment vehicle on the planet. Our experts show you how to play various ETF sectors to help pump-up your portfolio. Learn MoreOptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn MoreReal Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn MoreStocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn MoreTo begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
blog comments powered by Disqus
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 12,890.46 | 1,351.95 | 2,927.23 | 20.47 |
Oil *
118.75
|
|
UP
6.51 |
UP
1.99 |
UP
11.37 |
UP
0.72 |
10 Yr
2.05%
SPDR Gold
168.02
|
|
+0.05%
|
+0.15%
|
+0.39%
|
+3.65%
|
Data delayed 20 minutes |

Connect with TheStreet